Departmental Affiliations
Ilina Odouard, MPH ’23, focuses on influencing pharmaceutical policy changes that promote affordability, access, and health equity through regulatory and payment reform.
Research Interests
Prescription drugs, pharmaceutical policy, drug price negotiation, value-based payment, pharmaceutical innovation
Additional Links
Experiences & Accomplishments
Select Publications
Odouard, IC, Anderson, GF, Alexander, GC, Ballreich, J. Sociodemographic and spending characteristics of Medicare beneficiaries taking prescription drugs subject to price negotiations. Journal of Managed Care & Specialty Pharmacy. 2024;30(3), 269–278. doi: https://doi.org/10.18553/jmcp.2023.23153
Socal MP, Odouard IC, Kharrazi H. Ownership and Interoperability Challenges of Alzheimer Monoclonal Antibody Registries. JAMA Neurol. 2024;81(2):109–110. doi:10.1001/jamaneurol.2023.4675
Odouard IC, Socal MP, Anderson GF. Role of Registries in Medicare Coverage of New Alzheimer Disease Drugs. JAMA. 2023;330(14):1331–1332. doi:10.1001/jama.2023.17131
DiStefano MJ, Levy JF, Odouard IC, Anderson GF. Estimated savings from using added therapeutic benefit and therapeutic reference pricing in United States Medicare drug price negotiations. Value in Health. 2023. doi: https://doi.org/10.1016/j.jval.2023.08.004.